The nurse is administering an estrogen blocker to a client diagnosed with advanced breast cancer. Which of the following side effects will the nurse caution the client regarding?
Tendon rupture
Phlebitis
Increase risk of lymphomas
Thromboembolic events
The Correct Answer is D
A. Tendon rupture: Tendon rupture is not a side effect associated with estrogen blockers.
B. Phlebitis: While thromboembolic events are a risk, phlebitis (inflammation of a vein) is not a typical concern.
C. Increased risk of lymphomas: Estrogen blockers are not known to increase the risk of lymphomas.
D. Thromboembolic events: Estrogen blockers, such as tamoxifen, are associated with an increased risk of thromboembolic events (e.g., deep vein thrombosis, pulmonary embolism).
Free Nursing Test Bank
- Free Pharmacology Quiz 1
- Free Medical-Surgical Quiz 2
- Free Fundamentals Quiz 3
- Free Maternal-Newborn Quiz 4
- Free Anatomy and Physiology Quiz 5
- Free Obstetrics and Pediatrics Quiz 6
- Free Fluid and Electrolytes Quiz 7
- Free Community Health Quiz 8
- Free Promoting Health across the Lifespan Quiz 9
- Free Multidimensional Care Quiz 10
View Related questions
Correct Answer is D
Explanation
A. Regular sun exposure is needed to maximize drug efficacy: This is incorrect; in fact, doxycycline can cause photosensitivity, and sun exposure should be minimized.
B. Avoid water while taking this medication: Water should be taken with doxycycline to help prevent esophageal irritation.
C. Take this medication with antacids to relieve gastrointestinal symptoms: Antacids can also interfere with doxycycline absorption, so they should be avoided.
D. Avoid dairy products when taking this medication: Dairy products can bind to doxycycline and reduce its absorption in the gastrointestinal tract, which decreases its effectiveness. The client should avoid dairy when taking the medication.
Correct Answer is A
Explanation
A. Retinal toxicity: Chloroquine is associated with retinal toxicity, which can lead to vision changes or damage. Regular eye exams are necessary to monitor for early signs of toxicity.
B. Tumors: Chloroquine is not associated with the development of tumors.
C. Pancytopenia: This refers to a reduction in all blood cells and is not a known adverse effect of chloroquine.
D. Cancer: Chloroquine is not linked to an increased risk of cancer.